Individual differences and evidence-based psychopharmacology

BMC Medicine

Galila Agam¹  Yuly Bersudsky¹  RH Belmaker¹ 

[1] Ben Gurion University of the Negev, Beersheva, Israel

关键词: variability;    measurement error;    replicability;    individual differences;    clinical trials;    Variance;   

Others  :  857345
DOI  :  10.1186/1741-7015-10-110

 received in 2012-06-01, accepted in 2012-09-27,  发布年份 2012

【 摘 要 】

Individual differences in response to pharmacologic treatment limits the usefulness of mean data obtained from randomized controlled trials. These individual differences exist even in genetically uniform inbred mouse strains. While stratification can be of value in large studies, the individual patient history is the most effective currently available guide for personalized medicine in psychopharmacology.

【 授权许可】

   
2012 Belmaker et al; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Kent DM, Hayward RA: Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA 2007, 298(10):1209-1212.
• [2]Ebstein R, Belmaker R, Grunhaus L, Rimon R: Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature 1976, 259(5542):411-413.
• [3]Bersudsky Y, Shaldubina A, Agam G, Berry GT, Belmaker RH: Homozygote inositol transporter knockout mice show a lithium-like phenotype. Bipolar Disord 2008, 10(4):453-459.
• [4]Pickrell JK, Pai AA, Gilad Y, Pritchard JK: Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet 2010, 6(12):e1001236.
• [5]Taniguchi Y, Choi PJ, Li GW, Chen H, Babu M, Hearn J, Emili A, Xie XS: Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells. Science 2010, 329(5991):533-538.
• [6]Bersudsky Y, Applebaum J, Gaiduk Y, Sharony L, Mishory A, Podberezsky A, Agam G, Belmaker RH: Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. Bipolar Disord 2010, 12(4):376-382.
• [7]Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W: Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2007, 9(4):413-425.
• [8]Lichtenberg P, Belmaker RH: Subtyping major depressive disorder. Psychother Psychosom 2010, 79(3):131-135.
• [9]Belmaker RH: Patient history must be incorporated into any guidelines. Bipolar Disord 2009, 11(7):772. author reply 773
• [10]Kent DM, Shah ND: Risk models and patient-centered evidence: should physicians expect one right answer? JAMA 2012, 307(15):1585-1586.
• [11]Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA: Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 2010, 11:85. BioMed Central Full Text